Hormone replacement therapy and cardiovascular disease: A statement for healthcare professionals from the American Heart Association

Circulation

Volumn 104, Issue 4, 2001, Pages 499-503

  Mosca, Lori ^a   Collins, Peter ^a   Herrington, David M ^a   Mendelsohn, Michael E ^a   Pasternak, Richard C ^a   Robertson, Rose Marie ^a   Schenck Gustafsson, Karin ^a   Smith Jr , Sidney C ^a   Taubert, Kathryn A ^a   Wenger, Nanette K ^a  

^a AMERICAN HEART ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ANGIOGRAPHY; ATHEROSCLEROSIS; BREAST CANCER; CARDIOVASCULAR DISEASE; ESTROGEN THERAPY; HORMONE SUBSTITUTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 0035943052     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc2901.092200     Document Type: Review

References (32)

1. The protective effects of estrogen on the cardiovascular system
2. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
3. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration: PEPI Investigators: Postmenopausal Estrogen/Progestin Interventions
4. The role of hormone replacement therapy in the prevention of postmenopausal heart disease
5. Effect of postmenopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study
6. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) Research Group
7. Hormone replacement therapy and heart disease prevention: Experimentation trumps observation
8. Effects of estrogen replacement on the progression of coronary artery atherosclerosis
9. Coronary heart disease in women: An ounce of prevention
10. Coronary arteriography in estrogen-treated postmenopausal women
11. Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: A randomized, controlled trial
12. Hormone replacement therapy, heart disease, and other considerations
13. Estrogen and atherosclerosis
14. Design of the Women's Health Initiative clinical trial and observational study: The Women's Health Initiative Study Group
15. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: Pooled data from clinical trials
16. The Coronary Drug Project design and methods, and baseline results
17. Early risks of hormone therapy in patients with coronary heart disease
18. Hormone replacement therapy for secondary prevention of coronary heart disease
19. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women
20. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association
21. Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS)
22. A prospective observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease
23. Estrogen after ischemic stroke: Effect of estrogen replacement on risk of recurrent stroke and death in the Women's Estrogen for Stroke Trial (WEST)
24. Postmenopausal hormone therapy increases risk for venous thromboembolic disease: The Heart and Estrogen/progestin Replacement Study
25. The association of postmenopausal estrogen therapy with survival after myocardial infarction
26. Design and methods of the Raloxifene Use for the Heart (RUTH) Study
27. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques
28. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women
29. AHA/ACC scientific statement: Consensus panel statement: A guide to preventive cardiology for women
30. Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States: American Heart Association Women's Heart Disease and Stroke Campaign Task Force